Try our Advanced Search for more refined results
Alcon Inc.
-
Discovery | Filed: May 09, 2024 | Entered: May 09, 2024 Alcon Inc. et al v. Padagis Israel Pharmaceuticals Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of (1) Reply Expert Report of S. Craig Dyar, Ph.D. Regarding Secondary Considerations of Nonobviousness; (2) Expert Report of Henry D. Jampel, M.D., M.H.S.; and (3) Expert Report of DeForest McDuff, Ph.D. filed by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC.(Haney, Megan)
-
Order | Filed: May 09, 2024 | Entered: May 09, 2024 Alcon Inc. et al v. Padagis Israel Pharmaceuticals Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED ~Util - Terminate Motions
SO ORDERED, re 146 STIPULATION TO EXTEND TIME to submit a redacted version of docket items 140, 141 and 142 to May 17, 2024 filed by Alcon Vision, LLC, Alcon Laboratories, Inc., Alcon Inc. Signed by Judge William C. Bryson on 5/9/2024. (mpb)
-
Motion | Filed: May 09, 2024 | Entered: May 09, 2024 Alcon Inc. et al v. Padagis Israel Pharmaceuticals Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Stipulation to EXTEND Time
STIPULATION TO EXTEND TIME to submit a redacted version of docket items 140, 141 and 142 to May 17, 2024 - filed by Alcon Inc., Alcon Laboratories, Inc., Alcon Vision, LLC. (Russell, Andrew)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login